High Yield Large-Cap Pharma: Recent Performance and 5-Year Dividend Growth Analysis

Many investors appreciate the pharmaceutical manufacturer industry for its potential to produce both income and long-term growth. Several of the large-cap drug makers offer above-average yields, and have records of growing their business and payouts over the long term. Additionally, historically, many drug markers have acted resiliently during economic downturns and recessions. These companies are often considered defensive stocks. Many believe that this industry currently represents a strong long-term value, as several of these companies will continue to pay substantial dividends, benefit from emerging market growth, continue to develop new medical advancements and provide products that are so needed as to ensure continued demand even in the face of price increases due to inflation. These characteristics make many investors label this industry as recession proof (or at least recession resistant). I did a search for large-cap (over a $10 billion valuation) drug manufacturers that trade within on U.S. exchanges and... Read more